表紙
市場調査レポート

神経刺激装置の世界市場:2015年

Global Neurostimulation Devices Market 2015-2019

発行 TechNavio (Infiniti Research Ltd.) 商品コード 268730
出版日 ページ情報 英文 83 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.32円で換算しております。
Back to Top
神経刺激装置の世界市場:2015年 Global Neurostimulation Devices Market 2015-2019
出版日: 2015年06月17日 ページ情報: 英文 83 Pages
概要

世界の神経刺激装置の市場は、2014年から2019年にかけて、5.37%のCAGRで拡大する見込みです。

当レポートでは、世界の神経刺激装置の市場について調査し、市場および製品の概要、システム区分および地域別の市場規模の推移と予測、市場動向および市場成長への各種影響因子の分析、競合環境と市場シェア、主要ベンダーのプロファイルなどをまとめています。

第1章 エグゼクティブサマリー

第2章 略語リスト

第3章 分析範囲

  • 市場概要
  • 主要製品

第4章 市場分析の手法

  • 市場分析のプロセス
  • 分析手法

第5章 イントロダクション

  • 神経刺激装置の基本的な構成要素
  • 発生装置
  • リード
  • プログラマー

第6章 市場環境

  • 市場概要
  • 市場の規模と予測
  • 充電式・非充電式神経刺激装置
  • ファイブフォース分析

第7章 システム別市場

  • 世界のSCS (脊髄刺激) システム市場
    • 市場規模・予測
  • 世界のDBS (脳深部刺激) システム市場
    • 市場規模・予測
  • 世界のSNS (仙骨神経刺激) システム市場
    • 市場規模・予測
  • 世界のVNS (迷走神経刺激) システム市場
    • 市場規模・予測

第8章 地域別市場

  • 南北アメリカ
    • 市場規模・予測
  • 欧州・中東・アフリカ
    • 市場規模・予測
  • アジア太平洋
    • 市場規模・予測

第9章 購入基準

第10章 市場の成長促進要因

第11章 促進要因とその影響

第12章 市場の課題

第13章 促進要因・課題の影響

第14章 市場の動向

第15章 市場動向とその影響

第16章 ベンダー情勢

  • 競合シナリオ
    • 主なニュース
    • M&A
  • 市場シェア分析
  • 他の有力ベンダー

第17章 主要ベンダー分析

  • Medtronic
  • Boston Scientific
  • St. Jude Medical
  • Cyberonics
    • 重要データ
    • 事業概要
    • 事業区分
    • 事業別収益
    • 地域別収益
    • 事業戦略
    • 主な発展動向
    • SWOT分析、など

第18章 本シリーズの他のレポート

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: IRTNTR6144

About Neurostimulation Devices

Available pharmacological treatment for conditions such as chronic pain, epilepsy, Parkinson's disease, and depression are not sufficient for all patients at all stages of treatment. More than 100 million people suffer from these conditions in the US alone. Though drug therapy, physiotherapy, and surgeries are effective treatment options, they are not suitable for all patients. For example, approximately 15-20% of epilepsy patients are drug-resistant and require alternate treatment method. Neurostimulation is a potential alternative for patients for whom the drug therapy or surgery is not effective.

Neurostimulation devices are implantable devices that help in the therapeutic activation of the nervous systems. These devices deliver electrical stimulation to the brain and nervous systems for the treatment of various types of neurological disorders such as pain, epilepsy, Parkinson's disease, depression, obsessive-compulsive disorder, dystonia, and tremors. These devices target specific areas of the brain or spinal cord by blocking the pain messages before they reach the brain.

Technavio's analysts forecast the global neurostimulation devices market to grow at a CAGR of 5.37% over the period 2014-2019.

Covered in this Report

The report covers the present scenario and the growth prospects of the global neurostimulation devices market for the period 2015-2019. Based on devises, the market can be segmented into the following: SCS systems, DBS systems, SNS systems, VNS systems, and others.

Technavio's report, Global Neurostimulation Devices Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and APAC and EMEA; it also covers the global neurostimulation devices market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • APAC
  • EMEA

Key Vendors

  • Boston Scientific
  • Cyberonics
  • Medtronic
  • St. Jude Medical

Other Prominent Vendors

  • Aleva Neurotherapeutics
  • Atrotech
  • Autonomic Technologies
  • ElectroCore
  • Endostim
  • EnteroMedics
  • ImThera Medical
  • Inspire Medical Systems
  • Neuros Medical
  • NeuroMetrix
  • NeuroPace
  • NeuroSigma
  • Nevro
  • SPR Therapeutics
  • Synapse Biomedical

Market Driver

  • Rise in Prevalence of Neurological Disorders
  • For a full, detailed list, view our report

Market Challenge

  • Not First Line of Treatment Therapy
  • For a full, detailed list, view our report

Market Trend

  • Significant Increase in Product Development and Launches
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

  • 05.1. Basic Components of Neurostimulation Devices
  • 05.2. Generator
  • 05.3. Leads
  • 05.4. Programmer

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Rechargeable and Non-rechargeable Neurostimulation Devices
  • 06.4. Five Forces Analysis

07. Market Segmentation by Systems

  • 07.1. Global SCS Systems Market
    • 07.1.1. Market Size and Forecast
  • 07.2. Global DBS Systems Market
    • 07.2.1. Market Size and Forecast
  • 07.3. Global SNS Systems Market
    • 07.3.1. Market Size and Forecast
  • 07.4. Global VNS Systems Market
    • 07.4.1. Market Size and Forecast

08. Geographical Segmentation

  • 08.1. Neurostimulation Devices Market in Americas
    • 08.1.1. Market Size and Forecast
  • 08.2. Neurostimulation Devices Market in EMEA
    • 08.2.1. Market Size and Forecast
  • 08.3. Neurostimulation Devices Market in the APAC
    • 08.3.1. Market Size and Forecast

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape

  • 16.1. Competitive Scenario
    • 16.1.1. Key News
    • 16.1.2. Mergers and Acquisitions
  • 16.2. Market Share Analysis 2014
  • 16.3. Other Prominent Vendors

17. Key Vendor Analysis

  • 17.1. Medtronic
    • 17.1.1. Key Facts
    • 17.1.2. Business Overview
    • 17.1.3. Business Segmentation
    • 17.1.4. Revenue by Business Segmentation
    • 17.1.5. Revenue Comparison by Business Segmentation 2012 and 2013
    • 17.1.6. Revenue by Geographical Segmentation
    • 17.1.7. Business Strategy
    • 17.1.8. Key Developments
    • 17.1.9. SWOT Analysis
  • 17.2. Boston Scientific
    • 17.2.1. Key Facts
    • 17.2.2. Business Overview
    • 17.2.3. Business Segmentation
    • 17.2.4. Business Segmentation by Revenue 2013
    • 17.2.5. Business Segmentation by Revenue 2012 and 2013
    • 17.2.6. Geographical Segmentation by Revenue 2013
    • 17.2.7. Business Strategy
    • 17.2.8. Recent Developments
    • 17.2.9. SWOT Analysis
  • 17.3. St. Jude Medical
    • 17.3.1. Key Facts
    • 17.3.2. Business Description
    • 17.3.3. Business Segmentation
    • 17.3.4. Business Strategy
    • 17.3.5. Revenue Segmentation by Business
    • 17.3.6. Revenue by Geographical Segmentation
    • 17.3.7. Key Information
    • 17.3.8. SWOT Analysis
  • 17.4. Cyberonics
    • 17.4.1. Key Facts
    • 17.4.2. Business Overview
    • 17.4.3. Geographical Segmentation by Revenue 2014
    • 17.4.4. Business Strategy
    • 17.4.5. Recent Developments
    • 17.4.6. SWOT Analysis

18. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Components of Neurostimulation Devices
  • Exhibit 3: Global Neurostimulation Devices Market 2014-2019 ($ Millions)
  • Exhibit 4: Segmentation of Global Neurostimulation Devices Market by Systems
  • Exhibit 5: Segmentation of Global Neurostimulation Devices Market by Systems 2014
  • Exhibit 6: Global SCS Systems Market 2014-2019 ($ Millions)
  • Exhibit 7: Cost Distribution in Parkinson's Disease
  • Exhibit 8: Global DBS Systems Market 2014-2019 ($ Millions)
  • Exhibit 9: Global SNS Systems Market 2014-2019 ($ Millions)
  • Exhibit 10: Global VNS System Market 2014-2019 ($ Millions)
  • Exhibit 11: Segmentation of Global Neurostimulation Devices Market by Systems 2014-2019
  • Exhibit 12: Segmentation of Global Neurostimulation Devices Market by Systems 2014-2019 ($ Millions)
  • Exhibit 13: Snapshot of Global Neurostimulation Devices Market 2014-2019
  • Exhibit 14: Segmentation of Global Neurostimulation Devices Market by Geography in 2014
  • Exhibit 15: Common Conditions That Use Neurostimulation Devices
  • Exhibit 16: Disease Economic Burden in the US
  • Exhibit 17: Neurostimulation Devices Market in the Americas 2014-2019 ($ Millions)
  • Exhibit 18: Neurostimulation Devices Market in EMEA 2014-2019 ($ Millions)
  • Exhibit 19: Neurostimulation Devices Market in APAC 2014-2019 ($ Millions)
  • Exhibit 20: Segmentation of Global Neurostimulation Devices Market by Geography in 2014-2019
  • Exhibit 21: Segmentation of Global Neurostimulation Devices Market by Geography in 2014-2019 ($ Millions)
  • Exhibit 22: Global Neurostimulation Devices Market Share Analysis 2014
  • Exhibit 23: Key Takeaways: Medtronic
  • Exhibit 24: Key Takeaways: Boston Scientific
  • Exhibit 25: Key Takeaways: St. Jude Medical
  • Exhibit 26: Key Takeaways: Cyberonics
  • Exhibit 27: Medtronic Inc.: Business Segmentation
  • Exhibit 28: Medtronic Inc.: Revenue by Business Segmentation 2013
  • Exhibit 29: Medtronic Inc.: Revenue Comparison by Business Segmentation 2012 and 2013 (US$ million)
  • Exhibit 30: Medtronic Inc.: Revenue by Geographical Segmentation 2013
  • Exhibit 31: Boston Scientific: Business Segmentation
  • Exhibit 32: Boston Scientific: Business Segmentation by Revenue 2013
  • Exhibit 33: Boston Scientific: Business Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 34: Boston Scientific: Geographical Segmentation by Revenue 2013
  • Exhibit 35: St. Jude Medical: Business Segmentation
  • Exhibit 36: St. Jude Medical: Revenue by Business Segmentation 2013
  • Exhibit 37: St. Jude Medical: Revenue by Geographical Segmentation 2012
  • Exhibit 38: Cyberonics: Geographical Segmentation by Revenue 2014
Back to Top